James W. Traweek Jr., 10% Owner at REATA PHARMACEUTICALS INC (RETA), bought 28,440 shares at $17.56 ($500K) on 2016-06-06, disclosed to the SEC on 2016-06-08.
Open-market purchase of $500k RETA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.56 | 20,000 | $351K | 70.3% |
| 2 | $17.62 | 4,220 | $74K | 14.9% |
| 3 | $17.62 | 4,220 | $74K | 14.9% |
| Total | $17.58 avg | 28,440 | $500K | 100% |
| Filing → |
| RETA | BUY | 2017-12-29 | $484K | — | Filing → |
| RETA | BUY | 2017-12-28 | $705K | — | Filing → |
| RETA | BUY | 2017-12-15 | $6.9M | — | Filing → |